What is the best management approach for an adult ICU patient with a large atrial septal defect (ASD) secundum and left to right shunt experiencing constant desaturation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICU Management of Adult with Large Secundum ASD and Persistent Desaturation

In an adult ICU patient with a large secundum ASD and left-to-right shunt presenting with constant desaturation, you must immediately determine if shunt reversal (right-to-left) has occurred, as this represents either Eisenmenger physiology or acute hemodynamic decompensation—both requiring fundamentally different management than standard ASD closure protocols. 1

Immediate Diagnostic Assessment Required

Pulse oximetry at rest and during exercise is mandated to determine shunt direction and magnitude, as this is the critical first step that determines all subsequent management 1. The presence of desaturation in a patient with known left-to-right shunt suggests one of three scenarios:

  • Shunt reversal to right-to-left (Eisenmenger physiology or acute decompensation)
  • Bidirectional shunting with intermittent right-to-left component
  • Concomitant pulmonary pathology independent of the ASD

Essential Hemodynamic Evaluation

You must obtain urgent invasive hemodynamic assessment to measure 1:

  • PA systolic pressure relative to systemic pressure (critical threshold: >2/3 systemic is absolute contraindication to closure)
  • Pulmonary vascular resistance relative to systemic resistance (critical threshold: >2/3 systemic is absolute contraindication)
  • Qp:Qs ratio to quantify shunt magnitude
  • Net shunt direction under current ICU conditions

Management Algorithm Based on Hemodynamic Findings

Scenario 1: Right-to-Left Shunt or Eisenmenger Physiology

ASD closure is absolutely contraindicated and will cause death if PA systolic pressure is >2/3 systemic, PVR is >2/3 systemic resistance, or net right-to-left shunt is present 1. This represents established severe pulmonary vascular disease where closure causes acute RV failure 2, 3.

Management priorities:

  • Do not close the ASD under any circumstances 1
  • Optimize oxygenation with supplemental oxygen, but recognize limited benefit in fixed pulmonary vascular disease
  • Consider pulmonary vasodilator therapy (endothelin-receptor antagonists, PDE-5 inhibitors) for Eisenmenger syndrome, though data are limited 1
  • Consult pulmonary hypertension specialists immediately 4
  • Avoid systemic vasodilators that worsen right-to-left shunting
  • Maintain adequate systemic vascular resistance to prevent increased right-to-left shunt

Scenario 2: Preserved Left-to-Right Shunt with Borderline Pulmonary Pressures

If PA systolic pressure is 50-67% of systemic AND/OR PVR is 1/3 to 2/3 systemic resistance, but net left-to-right shunt persists with Qp:Qs ≥1.5:1 1:

  • Closure may be considered but requires evaluation by pulmonary hypertension experts before proceeding 1, 4
  • 100% oxygen challenge test can help assess reversibility of pulmonary vascular disease—if PVR decreases significantly with oxygen, this suggests some reversibility and potential operability 5
  • Stabilize acute ICU issues first before considering definitive closure
  • TEE or CMR imaging to fully characterize anatomy and exclude anomalous pulmonary venous connections 1

Scenario 3: Preserved Left-to-Right Shunt with Favorable Hemodynamics

If PA systolic pressure <50% systemic, PVR <1/3 systemic resistance, Qp:Qs ≥1.5:1, and RV enlargement present 1:

  • Transcatheter or surgical closure is indicated (Class I recommendation) to reduce RV volume and improve outcomes 1
  • Stabilize acute medical issues causing ICU admission before proceeding with closure
  • Investigate alternative causes of desaturation (pneumonia, pulmonary embolism, heart failure, etc.)
  • Echocardiographic imaging to guide closure approach 1

Critical ICU-Specific Considerations

Addressing the Desaturation

The desaturation itself requires immediate attention:

  • Rule out concomitant pulmonary pathology (pneumonia, ARDS, pulmonary embolism) that may be unrelated to ASD 6
  • Assess for acute LV dysfunction which can precipitate pulmonary edema and worsen gas exchange 6, 7
  • Evaluate for positional or ventilation-related shunt reversal in mechanically ventilated patients
  • Consider paradoxical embolism if neurological symptoms present 2, 4

Hemodynamic Optimization Before Closure Decision

  • Optimize volume status carefully—excessive preload can worsen left-to-right shunt, while hypovolemia can promote right-to-left shunt
  • Treat any acute RV dysfunction that may be contributing to shunt reversal
  • Avoid medications that increase PVR (hypoxia, hypercarbia, acidosis, high PEEP)
  • Maintain adequate systemic blood pressure to prevent right-to-left shunt augmentation

Mortality and Morbidity Context

Unoperated ASDs carry 25% mortality before age 27 and 90% mortality by age 60, making closure essential when hemodynamically appropriate 4. However, closure with established severe pulmonary vascular disease is fatal 2, 3. The critical distinction is whether pulmonary vascular disease is reversible or fixed.

Expected Outcomes with Appropriate Closure

When closure criteria are met 4:

  • Improvement in NYHA functional class
  • Reduction in RV systolic pressure, volumes, and dimensions
  • Early mortality approximately 1% in absence of PAH or major comorbidities
  • Serious complications ≤1% with device closure

Key Pitfalls to Avoid

  • Never assume desaturation equals closure contraindication—determine shunt direction first 1
  • Never close an ASD with PA pressure >2/3 systemic or PVR >2/3 systemic—this is uniformly fatal 1, 2, 3
  • Never delay hemodynamic assessment—clinical examination alone cannot determine operability 1, 5
  • Do not attribute all desaturation to the ASD—investigate concurrent pulmonary pathology 6
  • Avoid premature closure in unstable ICU patients—stabilize acute issues first before definitive intervention

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Atrial Septal Defect Closure Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Atrial Septal Defect Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Secundum Atrial Septal Defect (ASD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Atrial septal defect closure with left ventricular dysfunction.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016

Related Questions

What is the management for a patient with a history of Atrial Septal Defect (ASD) closure device placement and a current small left-to-right shunt?
What is the pre and post operative management for an adult patient with an atrial septal defect (ASD) with left to right shunt, severe tricuspid regurgitation (TR), and atrial fibrillation?
Are any medications needed for an asymptomatic adult with a left-to-right shunting atrial septal defect (ASD) and a normal-sized right ventricle?
What are the hemodynamic effects on oxygen saturation in a patient with Atrial Septal Defect (ASD)?
Is there a cardiac contraindication to cesarean section (C-section) versus per vaginal (PV) delivery in a patient with a history of atrial septal defect (ASD) and no recent echocardiogram?
Which of the following is true about contrast-induced nephropathy (CIN) in patients undergoing procedures with radiocontrast agents, particularly those with pre-existing renal impairment?
What is the optimal anesthetic approach for a patient with severe mitral regurgitation (MR) undergoing mitral valve replacement surgery?
What is the recommended dose of Naloxone (opioid antagonist) for managing opioid toxicity in a patient?
What is the recommended combined physical modality treatment for an adult patient with chronic pain or musculoskeletal injury?
What conditions are associated with schistocytes in a patient's blood smear?
What should be investigated in a 25-year-old female with no known co-morbid illnesses and elevated Blood Urea Nitrogen (BUN) levels, who is undergoing pre-employment clearance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.